================================================================================
|------------------------|
UNITED STATES | OMB APPROVAL |
SECURITIES AND EXCHANGE COMMISSION |------------------------|
WASHINGTON, D.C. 20549 |OMB Number: 3235-0058|
|Expires: June 30, 1994|
FORM 12b-25 |Estimated average burden|
|hours per response 2.50|
|------------------------|
------------------------
NOTIFICATION OF LATE FILING | SEC FILE NUMBER |
| 000-27592 |
------------------------
------------------------
(Check One): [X]Form 10-K [ ]Form 20-F [ ]Form 11-K | CUSIP NUMBER |
[ ]Form 10-Q [ ]Form N-SAR ------------------------
For Period Ended: June 30, 1999
-------------
[ ] Transition Report on Form 10-K
[ ] Transition Report on Form 20-f
[ ] Transition Report on Form 11-K
[ ] Transition Report on Form 10-Q
[ ] Transition Report on Form N-SAR
For Transition Period Ended:
------------------------------------------
- --------------------------------------------------------------------------------
Read Instruction (on back page) Before Preparing Form. Please Print or Type.
NOTHING IN THIS FORM SHALL BE CONSTRUED TO IMPLY THAT THE COMMISSION HAS
VERIFIED ANY INFORMATION CONTAINED HEREIN.
- --------------------------------------------------------------------------------
If the notification relates to a portion of the filing checked above, identify
the Item(s) to which the notification relates:
- --------------------------------------------------------------------------------
PART I--REGISTRANT INFORMATION
- --------------------------------------------------------------------------------
Full Name of Registrant
SCANTEK MEDICAL INC.
- --------------------------------------------------------------------------------
Former Name if Applicable
321 PALMER ROAD
- --------------------------------------------------------------------------------
Address of Principal Executive Office (Street and Number)
DENVILLE NJ 07834
- --------------------------------------------------------------------------------
City, State and Zip Code
PART II--RULES 12b-25(b) AND (c)
If the subject report could not be filed without unreasonable effort or expense
and the registrant seeks relief pursuant to Rule 12b-25(b), the following should
be completed. (Check box if appropriate)
(a) The reasons described in reasonable detail in Part II of this form
| could not be eliminated without unreasonable effort or expense:
|
| (b) The subject annual report, semi-annual report, transition report
| on Form 10-K, Form 20-F, 11-K, Form N-SAR, or portion thereof,
[X] | will be filed on or before the fifteenth calendar day following
| the prescribed due date; or the subject quarterly report of
| transition report on Form 10-Q, or portion thereof will be filed
| on or beforethe fifth calendar day following the prescribed due
| date; and
(c) The accountant's statement or other exhibit required by Rule
12b-25(c) has been attached if applicable.
PART III--NARRATIVE
State below in reasonable detail the reasons why the Form 10-K, 11-K, 10-Q,
N-SAR, or the transition report or portion hereof, could not be filed within the
prescribed time period. (ATTACH EXTRA SHEETS IF NEEDED)
INFORMATION FROM OUR FOREIGN SUBSIDIARY HAS NOT BEEN RECEIVED AS OF THIS DATE.
- --------------------------------------------------------------------------------
(ATTACH EXTRA SHEETS IF NEEDED)
SEC 1344 (11-91)
2-70
<PAGE>
PART IV--OTHER INFORMATION
(1) Name and telephone number of person to contact in regard to this
notification
PATRICIA FURNESS 973 366-5250
------------------- ------------- ------------------
(Name) (Area Code) (Telephone Number)
(2) Have all other periodic reports required under Section 13 or 15(d) of the
Securities Exchange Act of 1934 or Section 30 of the Investment Company Act
of 1940 during the preceding 12 months (or for such shorter) period that
the registrant was required to file such reports) been filed? If answer is
no, identify report(s).
[X] Yes [ ] No
- --------------------------------------------------------------------------------
(3) Is it anticipated that any significant change in results of operations from
the corresponding period for the last fiscal year will be reflected by the
earnings statements to be included in the subject report or portion
thereof?
[ ] Yes [X] No
If so, attach an explanation of the anticipated change, both narratively
and quantitatively, and, if appropriate, state the reasons why a reasonable
estimate of the results cannot be made.
- --------------------------------------------------------------------------------
SCANTEK MEDIAL INC.
--------------------------------------------------------
(Name of Registrant as Specified in Charter)
has caused this notification to be signed on its behalf by the undersigned
hereunto duly authorized.
Date September 27, 1999 By: /s/ PATRICIA FURNESS
------------------------------- ------------------------------------
Patricia Furness
INSTRUCTION: This form may be signed by an executive officer of the registrant
or by any other duly authorized representative. The name and title of the person
signing the form shall be typed or printed beneath the signature. If the
statement is signed on behalf of the registrant by an authorized representative
(other than an executive officer), evidence of the representative's authority to
sign on behalf of the registrant shall be filed with the form.
ATTENTION
- ---------------------------------- ------------------------------------
INTENTIONAL MISSTATEMENTS OR OMISSIONS OF FACT CONSTITUTE FEDERAL
CRIMINAL VIOLATIONS (SEE 18 U.S.C. 1001).
- --------------------------------------------------------------------------------
GENERAL INSTRUCTIONS
1. This form is required by Rule 12b-25 (17CFR 240.12b-25) of the General
Rules and Regulations under the Securities Exchange Act of 1934.
2. One signed original and four conformed copies of this form and amendments
thereto must be completed and filed with the Securities and Exchange
Commission, Washington, D.C. 20549, in accordance with Rule 0-3 of the
General Rules and Regulations under the Act. The information contained in
or filed with the form will be made a matter of public record in the
Commission files.
3. A manually signed copy of the form and amendments thereto shall be filed
with each national securities exchange on which any class of securities of
the registrant is registered.
4. Amendments to the notifications must also be filed on 12b-25 but need not
restate information that has been correctly furnished. The form shall be
clearly identified as an amended notification.
2-71
